Voriconazol y tamsulosina: interacción farmacológica clínicamente relevante
- 5 November 2020
- journal article
- letter
- Published by Elsevier BV in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 39 (7), 361-363
- https://doi.org/10.1016/j.eimc.2020.10.003
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodologyBMJ, 2013
- Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosinBritish Journal of Clinical Pharmacology, 2011
- Pharmacokinetic/Pharmacodynamic Profile of VoriconazoleClinical Pharmacokinetics, 2006
- Effect of concomitant administration of cimetidine hydrochloride on the pharmacokinetic and safety profile of tamsulosin hydrochloride 0.4 mg in healthy subjectsCurrent Therapeutic Research, 2002
- Identification of cytochrome P450 isozymes involved in metabolism of theα1-adrenoceptor blocker tamsulosin in human liver microsomesXenobiotica, 1998